World Orphan Drug Conference USA focuses on the most pressing challenges and opportunity to bring rare disease therapies to patient faster.
Neena Nizar with Harvard Medical School researchers, from left, Harald Jueppner, Thomas Gardella and John Potts. A research agreement between Harvard Medical School and the National Institutes of Health aims to develop a therapy for the condition that affects Nizar.
